Clinical Trial

PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria

Study acronym: PROACT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a pilot trial that builds on findings from the validation of prostate cancer risk calculators in Nigerian men. The goal of the overall study is to improve the early detection of prostate cancer in a high-risk population. The main questions the validation study aims to answer are: 1. How accurately do existing prostate cancer risk calculators identify Nigerian men with clinically significant prostate cancer? 2. Will a new risk calculator designed for Nigerian men more accurately identify those with clinically significant prostate cancer? The main questions the intervention study aims to answer is: Will the primary care provider-facing risk calculator be feasible and acceptable for primary care providers to implement? The intervention trial will be piloted among participants in community-level hospitals in order to primarily assess implementation outcomes
Trial Details
NCT Number NCT07733440
Lead Sponsor Ahmadu Bello University
Collaborators: Fogarty International Center of the National Institute of Health
Conditions Prostate Cancer, Risk Assessment, Clinical Decision Support Systems, Predictive Value of Tests, Models, Algorithms, Evidence-Based Practice, Implementation Research +7 more
Enrollment 89 participants
Start Date 2029-03
Primary Completion 2029-08 (estimated)
Study Completion 2029-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-29